YS Biopharma Announces Results of Extraordinary General Meeting
- Written by PR Newswire
![]() |
GAITHERSBURG, Md., May 22, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the results of its...
Read more: YS Biopharma Announces Results of Extraordinary General Meeting















